Kospi trading halted after 8% plunge as AI selloff spreads to Asia
South Korea's main stock index tripped a circuit breaker on Friday as the US tech rout hit chipmakers, prompting Seoul to ease margin-loan rules to limit forced selling.
South Korea's main stock index tripped a circuit breaker on Friday as the US tech rout hit chipmakers, prompting Seoul to ease margin-loan rules to limit forced selling.
Elon Musk said Tesla will phase out Cybertruck production at its Texas plant around mid-2027 to free space for its Cybercab robotaxi, after years of sales far below plan.
The Bank of England raised Bank Rate by a quarter point to 4%, its first increase since 2023, and now sees UK inflation climbing toward 5% by mid-2027.
Moderna beat third-quarter forecasts by a wide margin and now sees 2026 revenue growing 15% to 25%. Newer vaccines and sales abroad did the heavy lifting.
Employers hired at almost three times the expected pace and unemployment dipped to 4.1%, lifting bets that the Federal Reserve raises rates again in December.
The USDC issuer's third-quarter profit doubled analyst forecasts, but a one-off token sale did the heavy lifting while lower yields shrank its core interest income.
The Danish drugmaker's new weight-loss tablet brought in DKK 5.4bn in the third quarter, helping it raise guidance again after an August upgrade. Shares rose, though the stock is still down for 2026.
The global oil benchmark slipped under $100 a barrel for the first time in about a month after Democrats won Congress, as traders bet the vote makes a deal to end the Iran war more likely.
Neoclouds, SpaceX and bitcoin miners fell after Texas elected a governor who backs pausing new data centers. Analysts now expect slower, costlier AI construction.
Consumer prices in the euro area rose 4% in the year to October, driven by a 20.8% jump in energy costs. Markets now see a December ECB rate hike as more likely than not.
Belgian chemicals group Solvay signed a binding deal to take most of the magnet metals from a planned Brazilian mine, a step toward a supply chain that does not run through China.
CVS Health will separate its roughly 9,000 pharmacies from its insurance and drug-benefit arms by 2028. Shares fell more than 10% on Wednesday despite better-than-expected results.